person
as of 2026-07-01Herbert Y Meltzer, M.D.
Herbert Lachman, M.D.Herbert Meltzer, M.D.
at a glance
Roles: Principal Investigator, Study Chair
KOL signal score 5
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Vanderbilt University Medical Center
Roles
Principal Investigator, Study Chair
KOL signal
5
Publications
0 (0 high-value)
Trial investigator
yes
Trials led
8
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
NCT00178932—Completed
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
NCT00179062—Completed
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
NCT00664274—Unknown
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
NCT00179231—Completed
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
NCT00539071Phase 4Completed
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971Phase 3Completed
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
NCT00538122—Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR